Amitriptyline hydrochloride/Oxymetazoline Hydrochloride/Ketoprofen

盐酸阿米替林/盐酸羟甲唑啉/酮洛芬

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAmitriptyline hydrochloride/Oxymetazoline Hydrochloride/Ketoprofen

Drug Alias Name酮洛芬/盐酸阿米替林/盐酸羟甲唑啉Ketoprofen/oxymetazoline/amitriptylineKetoprofen/amitriptyline/oxymetazoline盐酸羟甲唑啉/酮洛芬/盐酸阿米替林Oxymetazoline/amitriptyline/ketoprofen +[10]

ClassificationSmall molecules

Mechanisms of ActionMonoamine reuptake inhibitorAlpha-1a adrenergic receptor agonistsCyclooxygenase-1 inhibitors +[4]

TargetsAlpha-1a adrenergic receptorCyclooxygenase-2Cyclooxygenase-1 +[4]

Therapy Area/IndicationsMeniscus InjuriesKnee InjuriesPain, Postoperative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsYes Amitriptyline hydrochloride Ketoprofen Oxymetazoline Hydrochloride

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesOmeros Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOmeros Corp

Active IndicationsN/A

Inactive IndicationsMeniscus InjuriesKnee InjuriesPain, Postoperative

Other Information

ATC CodeN/A